Peptide YY (1-36)

DB18348InvestigationalProtein Based Therapies

Peptide YY (1-36): Overview.

Mechanism: Pharmacologically active on Neuropeptide Y receptor type 4, Neuropeptide Y receptor type 2, and Neuropeptide Y receptor type 1
Curator reviewed
Code names: PYY

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Peptide YY (1-36), and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.